IQVIA Cell and Gene Therapy Center
Fact Sheet
Driving stem cell development from candidate identification through market authorization

The focus in Regenerative Medicine (RMx) is changing from bench medicine to clinical-commercial success. RMx faces many headwinds: complex preclinical/nonclinical models, constrained clinical manufacturing capacity, limited clinical sites with RMx experience, shifting regulatory landscape and an unclear pathway for pricing and market access.

Contact Us
Contact Us

Email Us

Interested in learning more about how IQVIA can create solutions to help you drive healthcare forward?

Call Us

We're available during standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.